What is ORTHOCON?
ORTHOCON is a developer of first-in-class surgical therapeutic devices, specializing in innovative materials for a variety of surgical procedures. The company's product portfolio features a range of hemostatic bone putties, engineered for straightforward application in orthopedic, trauma, spine, sports medicine, cranial, maxillofacial, and cardiothoracic surgeries. A key offering, the MONTAGE product, is a cohesive and resorbable hemostatic bone putty designed to adhere instantly to bleeding bone surfaces, aiming to enhance surgical outcomes by consolidating essential features and benefits for surgeons.
How much funding has ORTHOCON raised?
ORTHOCON has raised a total of $35M across 2 funding rounds:
Series A
$10M
Series B
$25M
Series A (2006): $10M with participation from BB Biotech Ventures and Canaan Partners
Series B (2009): $25M led by Canaan Partners, ProQuest Investment, and BB Biotech Ventures
Key Investors in ORTHOCON
BB Biotech Ventures
BB Biotech Ventures is a healthcare-focused venture capital firm that invests in private companies developing drugs and medical devices. They combine extensive experience with active networking and deep sector knowledge to create value for their investors.
Canaan Partners
Canaan Partners is an early-stage venture capital firm investing in technology and healthcare companies from seed through growth stages, with a focus on areas like biopharma and digital health.
ProQuest Investment
ProQuest Investment specializes in venture capital investments, particularly within the healthcare industry, typically investing more than $20 million in each company.
What's next for ORTHOCON?
The recent major strategic investment positions ORTHOCON for accelerated growth and market penetration. This capital infusion is expected to fuel further research and development, expand manufacturing capabilities, and bolster commercialization efforts for its advanced hemostatic bone putty technology. With a clear focus on improving surgical efficacy and patient recovery, ORTHOCON is poised to solidify its standing as a key innovator in the surgical device sector, leveraging this significant backing to drive its strategic objectives and capture greater market share.
See full ORTHOCON company page
